insights_auto
Why is SABS down 3.90%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.96
arrow_downward
-3.90%(-0.12) 1D
$3.00
arrow_upward
+1.35% (+0.040)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
266.66M
Avg. vol.
700.24K
Volume
658.12K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
266.66M
Avg. vol.
700.24K
Volume
658.12K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
qz.com
·
9 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
marketscreener.com
·
9 hours ago
S&P 500 Posts Weekly Gain as Energy Sector Leads Broad Climb
Investing.com
·
9 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.10%
Traders Union
·
15 hours ago
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio